| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 25.87 M CAD | 18.84 M CAD | -42.84 M CAD | -88.95 M CAD | -153.62 M CAD | -142.46 M CAD | -130.27 M CAD | -7.52 M CAD | -4.28 M CAD |
| Depreciation & Amortization | 14.23 M CAD | 9.34 M CAD | 8.11 M CAD | 13.12 M CAD | 15.40 M CAD | 7.04 M CAD | 3.91 M CAD | 1.94 M CAD | 768000 CAD |
| Stock-Based Compensation | 7.05 M CAD | 8.70 M CAD | 8.77 M CAD | 15.12 M CAD | 10.15 M CAD | 15.36 M CAD | 11.62 M CAD | 8.15 M CAD | — |
| Capital Expenditures | 25.72 M CAD | 12.41 M CAD | 2.50 M CAD | 3.45 M CAD | 11.14 M CAD | 31.41 M CAD | 38.66 M CAD | 88.31 M CAD | 32.93 M CAD |
| Cash Flow from Investing | -76.56 M CAD | 175.15 M CAD | -59.50 M CAD | -1.84 M CAD | -28.90 M CAD | 20.15 M CAD | -603.27 M CAD | -93.91 M CAD | — |
| Cash Flow from Financing | -19.91 M CAD | -1.23 M CAD | -1.03 M CAD | -2.90 M CAD | -13.44 M CAD | -5.46 M CAD | 1.86 B CAD | 122.11 M CAD | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 9.74 M CAD | 0 CAD | 0 CAD | — | — | — | — | — | — |
| Free Cash Flow | 149000 CAD | 6.43 M CAD | -45.34 M CAD | -92.40 M CAD | -164.76 M CAD | -173.87 M CAD | -168.94 M CAD | -95.83 M CAD | -37.20 M CAD |
Cronos Group Inc. is a global cannabinoid company focused on building iconic brands and advancing research, technology, and product development in medical and adult-use cannabis markets. It operates primarily in Canada, Israel, and international regions including Europe, offering a diverse portfolio of premium cannabis products such as flower, pre-rolls, vapes, gummies, and extracts. Key brands include Spinach® for innovative edibles and vapes like PUFFERZ™, SOURZ®, and seasonal flavors; Lord Jones® for high-potency live resin fusions and indoor-grown flower; and PEACE NATURALS® for medical cannabis distribution. The company leverages cultivation through Cronos GrowCo, emphasizing small-batch production, liquid diamonds infusion, and terpene-rich formulations to meet consumer demand for quality, convenience, and potency. Cronos Group Inc. pursues strategic international partnerships and transactions, such as expanding into Switzerland and the Netherlands' adult-use pilot program, positioning it as a key player in the evolving global cannabis industry. Founded in 2018 and headquartered in Toronto, Canada, it supports borderless product strategies across recreational and medicinal segments.